Literature DB >> 3653529

Effect of cisapride on the gastro-oesophageal function in normal human subjects.

L Wallin1, S Kruse-Andersen, T Madsen, S Boesby.   

Abstract

The aim of this study was to investigate oesophageal peristalsis and gastro-oesophageal function in normal subjects after 4 days of cisapride 10 mg p.o. 3 times/day and 10 mg 1.5 h before the investigation. The study was carried out in a double-blind cross-over design with coded cisapride or placebo tablets. Basal sphincter pressure increased after cisapride (p less than 0.002). The peristaltic pressure amplitude in the oesophageal body as well as the duration and velocity of the peristaltic pressure wave were measured after wet swallows. No changes were found. Intragastric pH was unchanged after cisapride. No effect was found on the result of a standard acid clearing test. Plasma concentration of cisapride did not correlate with any of the other variables. Oral cisapride increases fasting gastro-oesophageal sphincter pressure, but does not influence oesophageal peristalsis, acid clearing or intragastric pH in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3653529     DOI: 10.1159/000199494

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  9 in total

1.  Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study.

Authors:  Yong Sung Kim; Tae Hyeon Kim; Chang Soo Choi; Young Woo Shon; Sang Wook Kim; Geom Seog Seo; Yong Ho Nah; Myung Gyu Choi; Suck Chei Choi
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

Review 2.  Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.

Authors:  R W McCallum; C Prakash; D M Campoli-Richards; K L Goa
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 3.  Medical treatment of esophageal motility disorders.

Authors:  H D Allescher; W J Ravich
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

Review 4.  A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.

Authors:  J Tack; G Coremans; J Janssens
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

5.  The effect of cisapride on gastro-oesophageal dysfunction in systemic sclerosis: a controlled manometric study.

Authors:  A Kahan; S Chaussade; M Gaudric; B Freitag; B Amor; C J Menkes; G Strauch; J Guerre; D Couturier
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

6.  Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients.

Authors:  P Ceccatelli; J Janssens; G Vantrappen; S Cucchiara
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

Review 7.  Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

8.  Effect of cisapride on postprandial gastro-oesophageal reflux.

Authors:  R H Holloway; J Downton; B Mitchell; J Dent
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

Review 9.  Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders.

Authors:  J Tack; M Camilleri; L Chang; W D Chey; J J Galligan; B E Lacy; S Müller-Lissner; E M M Quigley; J Schuurkes; J H De Maeyer; V Stanghellini
Journal:  Aliment Pharmacol Ther       Date:  2012-02-22       Impact factor: 8.171

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.